ABBV vs CPRX · P/E 81, rev $16.99B vs P/E 18, rev $491.7M
AbbVie Inc (ABBV) versus Catalyst Pharmaceuticals Inc (CPRX) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported CPRX revenue for 2024-12-31 was $491.7M. Net income was $163.9M. Revenue was up 23.5% from 2023-12-31 to 2024-12-31. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
Not investment advice. Open the ABBV and CPRX stock pages for the full models.
Not investment advice.